Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)

Market Cap	12.21B
Revenue (ttm)	2.91B
Net Income (ttm)	478.28M
Shares Out	n/a
EPS (ttm)	2.29
PE Ratio	25.52
Forward PE	15.14
Dividend	0.19 (1.21%)
Ex-Dividend Date	May 20, 2025

Volume	727
Average Volume	213
Open	15.47
Previous Close	15.85
Day's Range	15.47 - 15.47
52-Week Range	12.40 - 16.42
Beta	0.54
RSI	35.24
Earnings Date	Nov 11, 2025

About RICFY

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1926
• Employees: 4,583
• Stock Exchange: OTCMKTS
• Ticker Symbol: RICFY

Financial Performance

In 2024, RICFY's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR